Skip to content

Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI

Effect of the Stage Specific Cognitive Intervention Program on Functional Cortical Activation in Alzheimer's Disease

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01329601
Acronym
ECIF
Enrollment
24
Registered
2011-04-06
Start date
2011-01-31
Completion date
2011-12-31
Last updated
2011-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia of the Alzheimer Type

Keywords

cognitive training, Alzheimer disease, tertiary prevention

Brief summary

The study aims to detect the effect of a structured cognitive rehabilitation program, teh stage specific intervention STACog, on cognitive performance and functional activation in fMRI in a group of patients with mild cognitive impairment and dementia due to Alzheimer's disease compared to a waiting group control sample. Baseline performance in cognitive tests and fMRI will further be assessed compared to healthy control subjects.

Detailed description

Subject of the proposed project is to offer based on existing theoretical principles and methods stage-related, reproducible, relevant to everyday life group training in German for people with aMCI and slightly severe AD and compared with a - in terms of goal variables - to be less effective prestigious intervention . It is believed that the active treatment - in the intervention group, the overall level of functioning can longer be maintained and that positive transfer effects on non-cognitive level - to achieve and cognitive level - here at nationals. In addition, information is expected that the conversion rate of people with dementia and aMCI cut to a further loss of independence in humans can be delayed slightly with severe AD. The project aims to provide data to estimate the effect sizes of intervention can be determined on the basis of group size and duration of ongoing investigations. Involving functional imaging measures, the intervention study, an adequate platform for the detection of intervention effects on neurobiological basis using fMRI dar. Here, the cerebral blood flow in specific activation as a measure of neuronal and synaptic activity and integrity both in cross-section of a subsample of healthy elderly people studied determined and changes in cerebral activity patterns in people with severe AD, aMCI or slightly in comparison pre-/post interventions. There are detectable much earlier in the pathogenesis of functional changes as structural, using fMRI, the study is to make a significant contribution to prove whether a modular cognitive intervention altered neural and synaptic activity and whether this change is accompanied by an improvement in cognitive performance. A complete and proven effectiveness of cognitive group training could make a significant contribution that people with MCI and severe AD easily submit their own initiative mental condition, and add itself to sustain the intellectual, emotional and social potential. As a long-term perspective, the results for the optimization of cognitive intervention programs and continue to implement the organizations of the open and contribute stationary the elderly and specialized medical facilities and other medical facilities.

Interventions

BEHAVIORALStaCog, stage specific cognitive Intervention

StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI

BEHAVIORALbooklet based training

Home based training of episodic memory using paper-pencil exercizes

Sponsors

DZNE, German Center for Neurodegenerative Disorders, Germany
CollaboratorUNKNOWN
University of Rostock
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of Mild Cognitive Impairment, Amnestic type (single domain) according to Petersen criteria or a low grade AD according to ICD-10/NINCDS-ADRDA

Exclusion criteria

* Major depression * severe visual and acoustic impairment * severe physical impairments * known malignancy * laboratory elevated inflammatory markers (ESR, CRP, leukocytes) * stroke * brain trauma * epilepsy * previous participation in a memory training * patients receiving drug treatment (antidepressants, neuroleptics, anti-dementia, other brain performance enhancing drugs) at least three months prior to study initiation for the duration of the project are at a stable dosage

Design outcomes

Primary

MeasureTime frameDescription
California Verbal Learning TestDetecting changes between two different time points (baseline and 6 months)Cognitive test for episodic memory

Secondary

MeasureTime frameDescription
functional cortical activity in fMRIDetecting changes between two different time points (baseline and 6 months)Measure of cortical activation during n-back letter recognition with emotional modulation

Countries

Germany

Contacts

Primary ContactStefan J. Teipel, Prof. Dr.
stefan.teipel@med.uni-rostock.de0049-381-494

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026